Previous Close | 193.44 |
1-Year Change | -19.89% |
6-Months Change | -19.28% |
3-Months Change | 1.26% |
Moving Avg (50d) | 200.59 |
Moving Avg (200d) | 219.94 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 34.1B |
Beta (3-Years) | 1.17 |
Revenue Growth (ttm) | 2.81% |
Net Profit Margin (ttm) | 8.91% |
Return On Assets (ttm) | 5.1% |
EPS (ttm) | 7.49 |
PE Ratio (ttm) | 25.83 |
Dividend Yield | % |
Asset Description: | IQVIA Holdings Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-02-10 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
197.309 | 203.112 | 206.981 | 212.784 | 222.456 | 232.128 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Life Sciences Tools & Services |
Country: | United States |